Pirfenidone Capsule
Product Images NDC 50228-441

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 50228-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pirfenidone 02)

A cumulative percentage plot comparing Pirfenidone and Placebo groups, showing the percentage of patients versus absolute change in percent predicted forced vital capacity (%FVC) from baseline to week 52. The graph distinguishes 'Worsening' (decrease in %FVC) and 'No Decline' (increase in %FVC) zones, with data points highlighting 90% and 77% patients in the no decline area for Placebo and Pirfenidone respectively.*

FDA Label Image

Figure 2 (Pirfenidone 03)

A line graph showing the mean change in forced vital capacity (FVC) in mL over 52 weeks for two groups: one treated with Pirfenidone and one with placebo. The x-axis represents time in weeks (0 to 52), and the y-axis shows the mean change in FVC. The Pirfenidone group shows a less steep decline compared to the placebo group, indicating a smaller reduction in FVC over time.*

FDA Label Image

Figure 3 (Pirfenidone 04)

A Kaplan-Meier survival curve showing the percentage of patients alive over time (in weeks) comparing Pirfenidone (n=623) and placebo (n=624). The graph includes patient counts at risk at different time points up to 120 weeks. Hazard ratio with 95% confidence interval is displayed on the graph.*

FDA Label Image

Principal Display Panel (267 mg 30 Capsules)

Label for Pirfenidone Capsules, 267 mg, by ScieGen Pharmaceuticals, Inc. The label states the capsule strength, quantity of 30 capsules, and includes storage instructions. It is identified as a prescription drug with barcode space and manufacturer information for ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

Principal Display Panel (267 mg 500 Capsules)

Label for Pirfenidone Capsules 267 mg by ScieGen Pharmaceuticals, Inc. The label shows the NDC 50228-441-05, states the strength as 267 mg per capsule, and includes storage instructions. The package contains 500 capsules and is marked Rx only.*

FDA Label Image

Chemical Structure (Pirfenidone Str 01)

Chemical structure diagram of pirfenidone, showing the arrangement of aromatic rings, nitrogen, and a methyl group, consistent with its molecular formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.